Invitrogen™ RARRES3 Polyclonal Antibody

Sheep Polyclonal Antibody

Supplier:  Invitrogen™ PA547815

Catalog No. PIPA547815

Description

In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) RARRES1 and rhLatexin is observed. Reconstitute at 0.2 mg/mL in sterile PBS.

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.

Specifications

• Antigen: RARRES3
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: PLAAT4
• Gene Alias: HRAS-like suppressor 4; HRASLS4; HRSL4; Phospholipase A and acyltransferase 4; PLA1/2-3; PLAAT4; RARRES3; RAR-responsive protein TIG3; retinoic acid receptor responder (tazarotene induced) 3; retinoic acid receptor responder 3; retinoic acid receptor responder protein 3; retinoic acid-inducible gene 1; retinoid-inducible gene 1 protein; RIG1; Tazarotene-induced gene 3 protein; TIG3
• Host Species: Sheep
• Purification Method: Antigen Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 5920
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Lyophilized

• Applications: Immunocytochemistry
• Concentration: 0.2 mg/mL
• Formulation: PBS with 5% trehalose and No Preservative
• Gene Accession No.: Q9UL19
• Gene Symbols: PLAAT4
• Immunogen: E. coli-derived recombinant human RARRES3 Asp12-Lys134.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG